Crsp stock forecast 2025.

Be the first to know when Wall Street analysts revise their ASML stock forecasts and price targets. Get Free ASML Updates. ASML stock forecasts by analyst. All Analysts Top Analysts. ... In 2025, ASML is forecast to generate $13,732,219,460,400 in revenue, with the lowest revenue forecast at $12,431,837,334,000 and the highest revenue forecast ...

Crsp stock forecast 2025. Things To Know About Crsp stock forecast 2025.

Stock Price Forecast. The 5 analysts offering 12-month price forecasts for Danimer Scientific Inc have a median target of 3.00, with a high estimate of 3.75 and a low estimate of 2.00. The median ... What is the current Price Target and Forecast for CRISPR Therapeutics (CRSP) CRISPR Therapeutics (CRSP) (Delayed Data from NSDQ) $66.73 USD -2.36 ( …The Veracyte stock forecast is 49.167390804547 USD for 2024 November 20, Wednesday; and 222.634 USD for 2028 November 20, Monday with technical analysis. Veracyte (VCYT) stock price prediction is 49.167390804547 USD.About the The Walt Disney Co. stock forecast. As of 2023 December 01, Friday current price of DIS stock is 92.210$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Walt Disney Co (The) stock price has been showing a declining tendency so we believe that similar market segments …See the latest CRISPR Therapeutics AG stock price (CRSP:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Nov 21, 2023 · The weighted average target price per CRISPR Therapeutics share in Dec 2023 is: 68.02. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 15.330% volatility is expected. CRISPR Therapeutics stock price predictions for 2023 using artificial intelligence.

Lithium Americas stock prediction for December 2024. In the beginning at 5.79. Maximum 6.00, minimum 5.12. The averaged price 5.62. At the end of the month 5.56 dollars, change for December -4.0%. Lithium Americas stock price forecast for January 2025. In the beginning at 5.56. Maximum 6.43, minimum 5.47.

Cash and securities were $1.9 billion as of March 31, 2023 and net loss was only $53.1 million for Q1 2023, so there is no danger of dilution in the near future. Under the Vertex Joint Development ...CRSP stock extended its rally from levels of around $107 in mid-November 2020 to $161 currently. Also, the stock has rallied a stellar 5x from levels of $34 in late March 2020 – when markets ...The CRISPR Therapeutics stock price gained 2.88% on the last trading day (Friday, 1st Dec 2023), rising from $66.73 to $68.65. During the last trading day the stock fluctuated 8.38% from a day low at $63.39 to a day high of $68.70. The price has been going up and down for this period, and there has been a 15.92% gain for the last 2 weeks.About the Microsoft Corp. stock forecast. As of 2023 December 02, Saturday current price of MSFT stock is 374.300$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Microsoft stock price as been showing a rising tendency so we believe that similar market segments …Stock Price Forecast. The 12 analysts offering 12-month price forecasts for Shell PLC have a median target of 75.10, with a high estimate of 88.00 and a low estimate of 66.00. The median estimate ...

Nov 30, 2023 · CRISPR Therapeutics will start 2025 at $49.04, then soar to $49.76 within the first six months of the year and finish 2025 at $57.16. That means +48% from today. CRISPR Therapeutics Stock Forecast 2030-2034. In this period, the CRISPR Therapeutics price would rise from $82.55 to $103.44, which is +25%.

Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...

Price target in 14 days: 83.058 USD. The best long-term & short-term CRISPR Therapeutics AG share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 with daily CRSP exchange price projections: monthly and daily opening, closing, maximum and minimum stock price outlook with smart technical analysis. Markets. Forecast . Price target. 89.68 0.00 0.00%. The 22 analysts offering 1 year price forecasts for CRSP have a max estimate of — and a min estimate of —. Analyst rating. Based on 28 analysts giving stock ratings to CRSP in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreAbout the Microsoft Corp. stock forecast. As of 2023 December 02, Saturday current price of MSFT stock is 374.300$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Microsoft stock price as been showing a rising tendency so we believe that similar market segments …The current CRISPR Therapeutics AG [ CRSP] share price is $66.73. The Score for CRSP is 52, which is 4% above its historic median score of 50, and infers lower risk than normal. CRSP is currently trading in the 50-60% percentile range relative to …The average twelve-month price prediction for CRISPR Therapeutics is $69.88 with a high price target of $110.00 and a low price target of $42.00. Learn more on CRSP's analyst rating history. Do Wall Street analysts like CRISPR Therapeutics more than its competitors?Detailed Monthly CRISPR Therapeutics (CRSP) Stock Forecast and Prediction for 2025 In the fast-paced biotech industry, forecasting stock performance is a mix of art and science. As we enter 2025, the journey of CRISPR Therapeutics’ stock stands at an intriguing crossroads.

Current. -$0.94. 1 Month Ago. -$1.09. 3 Months Ago. -$0.99. CRISPR Therapeutics AG analyst estimates, including CRSP earnings per share estimates and analyst recommendations.Wall Street Stock Market & Finance report, prediction for the future: You'll find the KYN Capital Group share forecasts, stock quote and buy / sell signals below. According to present data KYN Capital Group's KYNC shares and potentially its market environment have been in bearish cycle last 12 months (if exists).CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. CRSP.US updated stock price target summary ... FY 2025. CRSP will ...UBS Stock 12 Months Forecast. $31.25. (19.78% Upside) Based on 13 Wall Street analysts offering 12 month price targets for UBS Group AG in the last 3 months. The average price target is $31.25 with a high forecast of $38.08 and a low forecast of $19.77. The average price target represents a 19.78% change from the last price of $26.09.Mar 2, 2022 · The average TDOC stock price target stood at $124.77 a share, resulting in a potential 64% upside based on the last closing price of $75.86 (as of 28 February). The highest 12-month Teladoc share price forecast was $215, while the lowest was set at $67. Right after the company announced its results for the fourth quarter of the 2021 fiscal year ...

Let's take a closer look at Nio's growth over the years. In 2019, Nio produced 20,565 electric vehicles. It more than doubled its production to 43,728 units in 2020. Likewise, the company again ...

Adobe Inc. (NASDAQ:ADBE) announced its quarterly earnings data on Thursday, September, 14th. The software company reported $4.09 EPS for the quarter, topping the consensus estimate of $3.98 by $0.11. The software company had revenue of $4.89 billion for the quarter, compared to analysts' expectations of $4.87 billion.Stock Price Forecast. The 5 analysts offering 12-month price forecasts for Danimer Scientific Inc have a median target of 3.00, with a high estimate of 3.75 and a low estimate of 2.00. The median ... Lastly, social media stock Meta Platforms ( META -1.04%), the company formerly known as Facebook, should find itself as one of the 10 largest stocks in 2030. You'll note that current top-10 stocks ...CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. CRSP.US updated stock price target summary ... FY 2025. CRSP will ...Find real-time VTRS - Viatris Inc stock quotes, company profile, news and forecasts from CNN Business.Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Caribou Biosciences Inc have a median target of 23.00, with a high estimate of 30.00 and a low estimate of 13.00. The ...

22 thg 12, 2022 ... The news had a broad impact on gene-editing stocks including CRSP stock, which fell almost 3%. ... CRISPR Therapeutics Shows Rising Price ...

If we look at the company’s services, clients and according to stock market experts, 1st tdoc stock forecast 2025 can go up to 170.89 USD and 2nd tdoc stock price target is 192.75 USD in 2025, Teladoc Inc. has divided its services into 6 parts which include guidance and support, expert medical services, mental health services, platform and ...

Cash and securities were $1.9 billion as of March 31, 2023 and net loss was only $53.1 million for Q1 2023, so there is no danger of dilution in the near future. Under the Vertex Joint Development ...Mar 2, 2022 · The average TDOC stock price target stood at $124.77 a share, resulting in a potential 64% upside based on the last closing price of $75.86 (as of 28 February). The highest 12-month Teladoc share price forecast was $215, while the lowest was set at $67. Right after the company announced its results for the fourth quarter of the 2021 fiscal year ... Stock Price Forecast According to 16 stock analysts, the average 12-month stock price forecast for CRSP stock stock is $69.88, which predicts an increase of …Current. -$0.94. 1 Month Ago. -$1.09. 3 Months Ago. -$0.99. CRISPR Therapeutics AG analyst estimates, including CRSP earnings per share estimates and analyst recommendations.According to our current TSLA stock forecast, the value of Tesla shares will drop by -7.59% and reach $ 220.53 per share by December 6, 2023. According to our technical indicators, the current sentiment is Neutral while the Fear & Greed Index is showing 39 (Fear).TSLA stock recorded 15/30 (50%) green days with 5.95% price volatility over the last 30 days.Gene-editing therapies aren't common today, but years from now that could change. One company that hopes to be at the center of that transition is CRISPR Therapeutics ( CRSP -6.39%). The company...Forecast target price for 10-29-2023: $41.07. Positive dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 2.788%. Pessimistic ...The Palantir Technologies Inc - Class A stock forecast is 15.953138725275 USD for 2024 December 01, Sunday with technical analysis. Palantir Technologies Inc - Class A (PLTR) stock price prediction is 15.953138725275 USD. ... 2025 January: 2025 January 01, Wednesday: 14.541: 12.35985: 16.72215: 2025 January …Bionano Genomics Inc () Stock Market info Recommendations: Buy or sell Bionano Genomics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Bionano Genomics share forecasts, stock quote and buy / sell signals below.According to present data Bionano Genomics's BNGO shares and potentially its …2 days ago · The latest CRISPR Therapeutics stock prices, stock quotes, news, and CRSP history to help you invest and trade smarter. ... The 68 analysts offering price forecasts for CRISPR Therapeutics have a ... It's being developed as a one-time curative treatment for two blood disorders, sickle cell disease and beta thalassemia. Regulators in the U.S., the U.K., and Europe are reviewing the candidate as ...

About the Square, Inc. stock forecast. As of 2023 December 03, Sunday current price of SQ stock is 65.040$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Block Inc - Class A stock price as been showing a rising tendency so we believe that similar market segments were very …RVLV Stock 12 Months Forecast. $14.73. (0.48% Upside) Based on 14 Wall Street analysts offering 12 month price targets for Revolve Group in the last 3 months. The average price target is $14.73 with a high forecast of $18.00 and a low forecast of $10.50. The average price target represents a 0.48% change from the last price of $14.66.Target values for the price of one CRISPR Therapeutics share for Nov 2026. The weighted average target price per CRISPR Therapeutics share in Nov 2026 is: 45.09. In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 10.682% volatility is expected. Pessimistic target level: 43.43.CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. CRSP updated stock price target summary.Instagram:https://instagram. transfer brokerage accountbest indices trading platformday trading with schwabjeremy granthan For TELADOC HEALTH INC stock forecast for 2023, 2 predictions are offered for each month of 2023 with average TELADOC HEALTH INC stock forecast of $19.58, a high forecast of $20.12, and a low forecast of $19.04. The average TELADOC HEALTH INC stock forecast 2023 represents a 4.7% increase from the last price of $18.7000007629395.CRISPR Therapeutics AG Stock (CRSP) is expected to reach an average price of $116.58 in 2025, with a high prediction of $154.57 and a low estimate of $78.58. This indicates an … solarcity costswing trading stock picks The average SunPower stock forecast 2031 represents a 736.89% increase from the last price of $4.01999998092651. For SunPower stock forecast for 2033 (10 year), 10 predictions are offered for each month of 2033 with average SunPower stock forecast of $34.36, a high forecast of $34.5, and a low forecast of $34.21.People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing. biolife solutions stock The average TDOC stock price target stood at $124.77 a share, resulting in a potential 64% upside based on the last closing price of $75.86 (as of 28 February). The highest 12-month Teladoc share price forecast was $215, while the lowest was set at $67. Right after the company announced its results for the fourth quarter of the 2021 fiscal …The current CRISPR Therapeutics AG [ CRSP] share price is $66.73. The Score for CRSP is 52, which is 4% above its historic median score of 50, and infers lower risk than …Track CRISPR Therapeutics AG (CRSP) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors